BactiBlock against Multidrug-Resistant Bacteria

According to the World Health Organization (WHO), antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases.

Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines or other antimicrobial products, making infections harder to treat and increasing the risk of disease spread, severe illness and death. As a result of drug resistance, antibiotics and other antimicrobial products become ineffective and infections become increasingly difficult or impossible to treat.

Taking this into consideration, studying BactiBlock capabilities against multi-drug resistance bacteria seemed something definitively necessary. Hence, specific tests have been carried out at an external laboratory with the aim of showing such kind of activity for BactiBlock 920 B4 and BactiBlock 101 R4.47.

The list of microorganisms has been chosen considering the WHO criteria and priorities established by them:

Priority 1: CRITICAL

Acinetobacter baumannii, carbapenem-resistant (Acinetobacter baumannii NCTC 13302)
Pseudomonas aeruginosa, carbapenem-resistant (Pseudomonas aeruginosa NCTC 13437)
Enterobacteriaceae, carbapenem-resistant, ESBL-producing (Escherichia coli NCTC 13353, Salmonella CIP 107220)

Priority 2: HIGH

Enterococcus faecium, vancomycin-resistant (Enterococcus faecium CECT 5253)
Staphylococcus aureus, methicillin-resistant, (Staphylococcus aureus CECT 5190)

Priority 3: MEDIUM

Streptococcus pneumoniae, penicillin-non-susceptible (Streptococcus pneumoniae CIP 10447

Results confirmed that in all cases and at usual addition levels, BactiBlock 920 B4 and BactiBlock 101 R4.47, thanks to its silver antimicrobial technology, are still highly effective. Since these critical microorganisms don’t have effective treatment at the moment, the effectiveness of BactiBlock against them can be considered has a highly promising result.

Previous news

BactiBlock® antimicrobial pet products

Pet ownership in Europe (and abroad) has shown continuous growth, driven by factors like urban living and increased appreciation for companionship, particularly during the pandemic. According to a recent survey, nearly 50% of households by now have a pet, ranging from...

BactiBlock® antimicrobial products for the summer

Summer is already here and that means plenty of plans and celebrations! This could be a time for significant gatherings, like local festivals, celebrations of personal milestones, or other community events. Celebrations can bring people together, fostering a sense of...

BactiBlock® will exhibit at FOAM EXPO NORTH AMERICA!

This new edition of Foam Expo North America will take place in June 24-26, 2025 at Suburban Collection Showplace, Novi, Michigan and BactiBlock® will be there! Foam Expo is the continent's largest foam event, offering three days of networking, innovation, and business...

New consumption habits & listeria infections

Have you heard about a bacteria called Listeria? Listeria monocytogenes is a well-known and feared bacteria, specially when it comes to the agri-food industry. This widespread bacteria posses a great resistance to particular conditions and, because of that, it can be...

BactiBlock® treated artificial grass

Artificial grass or turf consists of a surface made from synthetic fibres, which designers engineer to imitate natural grass's aesthetic qualities and feel. It is much more durable than natural grass and easily maintained without irrigation or trimming. Stadiums and...